The system, which has received CE Mark approval in Europe, adds to an increasingly crowded field of PFA technologies.

Upcoming data presentations, such as the five-year low ... management showed increased confidence in cardiovascular growth and PFA adoption. Q3 saw continued mid-single-digit revenue growth ...

Abbott's Volt™ PFA System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial fibrillation Pulsed field ablation – or PFA – uses high energy ...

Abbott (NYSE: ABT) today announced it has received CE Mark in Europe for the Volt™ PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has ...